NCT01303978View on ClinicalTrials.gov

Phase II Proof-of-concept Study of APD421

PHASE2CompletedINTERVENTIONAL

Enrollment

51

Participants

Timeline

Start Date

February 28, 2011

Primary Completion Date

July 31, 2012

Study Completion Date

July 31, 2012

Conditions

Chemotherapy-induced Nausea and Vomiting

Interventions

DRUG

APD421

Single dose

Trial Locations (4)

Unknown

Herlev Hospital, Copenhagen

Rigshospitalet, Copenhagen

Odense University Hospital, Odense

University Hospital of South Manchester NHS Trust, Manchester

Sponsors

Lead Sponsor

Acacia Pharma Ltd

All Listed Sponsors

lead

Acacia Pharma Ltd

INDUSTRY